Regarding the last, the prostate-specific membrane antigen (PSMA) has received considerable attention as an optical imaging target because of its abundant expression on the surface of most prostate cancer cells and the synthetic accessibility of fluorescent conjugates of urea-based PSMA-binding affinity agents [13,14,15,16,17,18]. This evidence concerns the gene FOLH1 and prostate cancer.